Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
5290 Vertex
- 1911
- +35+1.87%
20min DelayMarket Closed Dec 16 15:30 JST
55.14BMarket Cap13.49P/E (Static)
1920High1886Low7.00KVolume1914Open1876Pre Close13.36MTurnover223952wk High0.07%Turnover Ratio28.85MShares148352wk Low147.73EPS TTM20.18BFloat Cap2239Historical High13.49P/E (Static)10.56MShs Float318Historical Low141.63EPS LYR1.81%Amplitude40.00Dividend TTM1.45P/B100Lot Size2.09%Div YieldTTM
Vertex Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | 12.25%7.06B | -10.16%6.29B | 21.18%7B | 27.57%5.78B | 71.78%4.53B | 2.64B |
| Net profit before non-cash adjustment | -0.45%5.88B | -7.66%5.9B | 15.85%6.39B | 52.40%5.52B | -45.36%3.62B | --6.62B |
| Total adjustment of non-cash items | -43.26%854.28M | 308.20%1.51B | -72.83%368.84M | 32.60%1.36B | 130.13%1.02B | ---3.4B |
| -Depreciation and amortization | 29.08%1.35B | 27.25%1.05B | -24.11%821.38M | 8.90%1.08B | 30.11%993.91M | --763.87M |
| -Reversal of impairment losses recognized in profit and loss | --86.88M | --0 | ---- | 78,282.46%223.39M | -99.82%285K | --161.91M |
| -Share of associates | 53.19%7.94M | -67.42%5.19M | 16,476.04%15.91M | -99.44%96K | 171.99%17.27M | ---23.99M |
| -Disposal profit | -48.02%-11.54M | 83.74%-7.79M | 44.78%-47.94M | 50.61%-86.81M | -3,170.66%-175.77M | ---5.37M |
| -Net exchange gains and losses | 63.43%-64K | -16.67%-175K | -33.93%-150K | -386.96%-112K | -103.49%-23K | --659K |
| -Other non-cash items | -224.80%-578.02M | 210.18%463.18M | -403.61%-420.37M | -26.36%138.46M | 104.38%188.02M | ---4.29B |
| Changes in working capital | 129.68%331.5M | -561.89%-1.12B | 122.07%241.8M | -861.44%-1.1B | 80.70%-113.97M | ---590.52M |
| -Change in receivables | -528.46%-562.31M | -85.47%131.24M | 671.07%903.3M | -115.02%-158.18M | 138.68%1.05B | ---2.72B |
| -Change in inventory | 395.72%192.41M | 106.60%38.81M | -1,013.77%-588.36M | -117.52%-52.83M | 88.66%301.44M | --159.78M |
| -Change in payables | 304.51%1.13B | -1,184.26%-552.79M | 93.83%-43.04M | 66.66%-698.08M | -199.67%-2.09B | --2.1B |
| -Provision for loans, leases and other losses | 41.55%-429.08M | -2,338.88%-734.1M | 83.88%-30.1M | -129.86%-186.68M | 588.66%625.27M | ---127.96M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | -10.42%-29.03M | 0.31%-26.29M | 35.73%-26.37M | -65.95%-41.03M | -8.24%-24.72M | -22.84M |
| Interest received (cash flow from operating activities) | -15.90%33.54M | -5.90%39.88M | 9.84%42.38M | -5.66%38.59M | 43.01%40.9M | 28.6M |
| Tax refund paid | 39.73%-1.47B | -20.84%-2.44B | -30.27%-2.02B | 3.14%-1.55B | -184.03%-1.6B | -564.46M |
| Other operating cash inflow (outflow) | 0 | -1K | 0 | 0 | 0 | 0 |
| Operating cash flow | 44.89%5.59B | -22.73%3.86B | 18.28%5B | 43.52%4.22B | 41.60%2.94B | --2.08B |
| Investing cash flow | ||||||
| Net PPE purchase and sale | 38.93%-809.84M | -8.62%-1.33B | -147.16%-1.22B | 15.73%-493.91M | 72.87%-586.1M | ---2.16B |
| Net intangibles purchase and sale | -273.32%-56.27M | 88.47%-15.07M | -3.18%-130.69M | -842.32%-126.67M | -29.54%-13.44M | ---10.38M |
| Net business purchase and sale | --0 | ---2.3B | --0 | 130.29%36.09M | -495.70%-119.14M | ---20M |
| Net investment product transactions | 417.13%238.71M | -337.66%-75.27M | -110.64%-17.2M | 546.65%161.66M | --25M | ---- |
| Advance cash and loans provided to other parties | 81.76%-600K | ---3.29M | --0 | 99.49%-450K | -217.87%-87.66M | ---27.58M |
| Repayment of advance payments to other parties and cash income from loans | -5.88%16.63M | -1.54%17.67M | -6.27%17.94M | -52.19%19.14M | 121.62%40.04M | --18.07M |
| Net changes in other investments | -88.87%85.12M | 264.91%764.98M | 2,958.15%209.64M | 101.65%6.86M | -471.51%-415.94M | ---72.78M |
| Investing cash flow | 82.11%-526.25M | -157.80%-2.94B | -187.22%-1.14B | 65.67%-397.28M | 49.09%-1.16B | ---2.27B |
| Financing cash flow | ||||||
| Net issuance payments of debt | 3.86%-548.8M | 54.84%-570.86M | -1,241.22%-1.26B | 132.41%110.76M | -1,511.22%-341.76M | --24.22M |
| Net common stock issuance | -3.88%-800.13M | -38.14%-770.28M | -169.91%-557.61M | 59.47%-206.59M | -429.10%-509.66M | ---96.33M |
| Increase or decrease of lease financing | 72.65%-2.24M | 10.78%-8.18M | 36.28%-9.17M | 6.03%-14.39M | 22.81%-15.31M | ---19.83M |
| Cash dividends paid | -11.75%-801.15M | 8.92%-716.91M | -48.91%-787.09M | 17.08%-528.56M | -69.22%-637.46M | ---376.7M |
| Net other fund-raising expenses | ---1K | ---- | ---- | 0.00%-1K | 0.00%-1K | ---1K |
| Financing cash flow | -4.17%-2.15B | 21.07%-2.07B | -309.83%-2.62B | 57.53%-638.78M | -220.96%-1.5B | ---468.65M |
| Net cash flow | ||||||
| Beginning cash position | -9.46%10.98B | 11.35%12.13B | 41.36%10.89B | 3.79%7.71B | 16.05%7.43B | --6.4B |
| Current changes in cash | 353.86%2.91B | -192.85%-1.15B | -61.21%1.24B | 1,033.22%3.19B | 142.40%281.25M | ---663.35M |
| Effect of exchange rate changes | -63.43%64K | 16.67%175K | 33.93%150K | 386.96%112K | 103.49%23K | ---659K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | --1.69B |
| End cash Position | 26.53%13.9B | -9.46%10.98B | 11.35%12.13B | 41.36%10.89B | 3.79%7.71B | --7.43B |
| Free cash flow | 82.17%4.44B | -26.08%2.44B | 4.32%3.3B | 74.59%3.16B | 1,794.62%1.81B | ---106.76M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |